Latest p/e ratio
Clinuvel Pharmaceuticals P/E ratio
Direct answer
Clinuvel Pharmaceuticals's p/e ratio is 12.23x.
The verified market snapshot reports 12.23x.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 28, 2026.
Get free Clinuvel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- P/E ratio
- 12.23x
Explore related company data
View Clinuvel Pharmaceuticals's market capitalizationView Clinuvel Pharmaceuticals's price-to-book ratioView Clinuvel Pharmaceuticals's return on equityView Clinuvel Pharmaceuticals's dividend yieldView Clinuvel Pharmaceuticals's 52-week price rangeView Clinuvel Pharmaceuticals's revenue growthView Clinuvel Pharmaceuticals's profit marginView Clinuvel Pharmaceuticals's debt-to-equity ratioView all Clinuvel Pharmaceuticals key metricsReturn to Clinuvel Pharmaceuticals profile